Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 1
This trial is looking at a drug called LDE225 alongside gemcitabine chemotherapy for cancer of the pancreas that has spread.
Recruitment start: 5 March 2012
Recruitment end: 10 October 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Palmer
Novartis
Last reviewed: 23 November 2015
CRUK internal database number: 9326